Featured Research

from universities, journals, and other organizations

Overuse of radioactive iodine for thyroid cancer highest in regions with poor health care access

Date:
October 16, 2013
Source:
American Thyroid Association
Summary:
Socioeconomic factors used to rank the different geographic regions that together are associated with higher use of radioactive iodine (RAI). These factors include significantly lower levels of income, education, and white collar employment.

The American Thyroid Association (ATA) recommends against the routine use of radioactive iodine after surgery to remove the thyroid in patients with low-risk papillary thyroid cancer (PTC). Yet more than 30% of these patients receive radioactive iodine (RAI) treatment in the U.S. A new study presented at the upcoming annual meeting of the ATA finds that overutilization of RAI is more common in regions of the country where people have worse access to health care.

Related Articles


J. Marti and colleagues from Beth Israel Medical Center and Memorial Sloan-Kettering Cancer Center, New York, NY analyzed more than 13,000 cases of very low risk classical PTC across the U.S. in which patients underwent total thyroidectomy. They report that patterns of RAI use in these patients vary dramatically. Over a 19-year period, the proportion of patients who received RAI ranged from 30-36%.

In a presentation entitled "Overutilization of RAI for Very Low Risk Thyroid Cancer Is Most Frequent in Regions with Poorer Healthcare Access," the researchers describe a composite of socioeconomic factors used to rank the different geographic regions that together are associated with higher use of RAI. These factors include significantly lower levels of income, education, and white collar employment, and higher levels of uninsured, non-English speaking, and poor persons. The people living in these regions have poorer access to health care and, likely, to experienced specialists.

This study will be presented as part of an oral presentation delivered at the 83rd Annual Meeting of the American Thyroid Association, October 16-20, 2013, in San Juan, Puerto Rico.

"Radioiodine therapy has potential toxicity and financial costs, yet a substantial number of low risk thyroid cancer patients receive this therapy despite little to no chance of benefit," says Ronald J. Koenig, M.D., Ph.D., Program Committee Co-Chair, and Professor, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor. "In order to minimize the overuse of RAI, it is first necessary to identify the factors that lead to this overuse. The study by Marti and colleagues helps to do this, identifying socioeconomic factors that correlate with RAI overuse. Importantly, their data suggest the problem may be inadequate access to appropriate specialists, a problem that should be remediable."


Story Source:

The above story is based on materials provided by American Thyroid Association. Note: Materials may be edited for content and length.


Cite This Page:

American Thyroid Association. "Overuse of radioactive iodine for thyroid cancer highest in regions with poor health care access." ScienceDaily. ScienceDaily, 16 October 2013. <www.sciencedaily.com/releases/2013/10/131016095847.htm>.
American Thyroid Association. (2013, October 16). Overuse of radioactive iodine for thyroid cancer highest in regions with poor health care access. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2013/10/131016095847.htm
American Thyroid Association. "Overuse of radioactive iodine for thyroid cancer highest in regions with poor health care access." ScienceDaily. www.sciencedaily.com/releases/2013/10/131016095847.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins